FDA approves Zostavax vaccine to prevent shingles in individuals 50 to 59 years of age

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: FDA approves Zostavax vaccine to prevent shingles in individuals 50 to 59 years of age

FDA approves Zostavax vaccine to prevent shingles in individuals 50 to 59 years of age
Thu, 24 Mar 2011 16:04:00 -0500

The Food and Drug Administration (FDA) today approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? support@xxxxxxxxxxxxxxx
• Other inquiries? webmail@xxxxxxxxxx

U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420